8-K
filed April 6, 2023, 7:59 PM ET
CIK 0000849636
other material
confidence high
sentiment neutral
materiality 0.25
RespireRx raises $25,000 via sale of 250 shares of Series I 8% Redeemable Preferred Stock
RespireRx Pharmaceuticals Inc.
- Raised $25,000 from two accredited investors for 250 shares of Series I 8% Redeemable Preferred Stock.
- Series I Preferred Stock carries 8% annual dividend payable in shares; redeemable upon events like license payments ≥$15M.
- Preferred stock is not convertible into common stock; transfer restricted except to family or affiliates.
- As of April 4, 2023, common shares outstanding: 144,326,672.
- Issuance exempt from registration under Section 4(a)(2) of the Securities Act.
Key facts
Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
RespireRx Pharmaceuticals Inc.: Filed Certificate of Designation for Series I Preferred Stock to amend the certificate of incorporation, setting forth preferences, rights and limitations of the new series (effective 2023-04-03).
- Change
- charter amendment
- Effective
- 2023-04-03
Exact text from the filing
On April 3, 2023, the Company filed a Certificate of Designation, Preferences, Rights and Limitations of its Series I Preferred Stock, also referred to herein as the “Certificate” with the Secretary of State of the State of Delaware to amend the Company’s certificate of incorporation.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
RespireRx Pharmaceuticals Inc. entered into Securities Purchase Agreement with two individual accredited investors investing jointly valued at $25,000.00 (effective 2023-04-05).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- two individual accredited investors investing jointly
- Value
- $25,000.00
- Effective
- 2023-04-05
Exact text from the filing
On April 5, 2023, RespireRx Pharmaceuticals Inc. (the “Company” or the “Corporation”) entered into a securities purchase agreement (“Securities Purchase Agreement) with two individual accredited investors investing jointly (“Investors”). Pursuant to the terms of the Securities Purchase Agreement, the investors invested $25,000.00 for 250 shares of Series I 8% Redeemable Preferred Stock
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.